DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
-4.5%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$33.8B
AUM Growth
-$562M
(-1.6%)
Cap. Flow
+$876M
Cap. Flow
% of AUM
2.59%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
1,460
New
97
Increased
616
Reduced
423
Closed
88
Top Buys
| 1 |
NVIDIA
NVDA
|
+$117M |
| 2 |
L3Harris
LHX
|
+$81.2M |
| 3 |
PNC Financial Services
PNC
|
+$70.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$69.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$68.1M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$71M |
| 2 |
Linde
LIN
|
+$51.8M |
| 3 |
Amazon
AMZN
|
+$42.6M |
| 4 |
Meta Platforms (Facebook)
META
|
+$37M |
| 5 |
Encompass Health
EHC
|
+$35.8M |
Sector Composition
| 1 | Technology | 24.13% |
| 2 | Healthcare | 19.65% |
| 3 | Financials | 10.78% |
| 4 | Industrials | 9.28% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Nuvalent
NUVL
$5.65B
| $1.21M | ﹤0.01% |
60,000
+30,000
| +100% | +$604K |
|
827
BILL Holdings
BILL
$5.4B
| $1.21M | ﹤0.01% |
9,090
+1,438
| +19% | +$191K |
|
828
Beam Therapeutics
BEAM
$2.03B
| $1.2M | ﹤0.01% |
25,000
+11,000
| +79% | +$528K |
|
829
PTC Therapeutics
PTCT
$4.65B
| $1.2M | ﹤0.01% |
24,000
+7,200
| +43% | +$359K |
|
|
ZEN
830
DELISTED
ZENDESK INC
ZEN
| $1.2M | ﹤0.01% |
15,891
+2,983
| +23% | +$225K |
|
831
Elanco Animal Health
ELAN
$9.38B
| $1.2M | ﹤0.01% |
95,428
+8,802
| +10% | +$110K |
|
832
MGIC Investment
MTG
$6.5B
| $1.2M | ﹤0.01% |
92,410
+2,210
| +2% | +$28.6K |
|
833
LivaNova
LIVN
$3.1B
| $1.19M | ﹤0.01% |
25,000
| – | – |
|
|
BERY
834
DELISTED
Berry Global Group, Inc.
BERY
| $1.19M | ﹤0.01% |
27,987
| – | – |
|
835
Kilroy Realty
KRC
$4.99B
| $1.19M | ﹤0.01% |
29,015
-31,488
| -52% | -$1.29M |
|
836
Royal Caribbean
RCL
$91.4B
| $1.18M | ﹤0.01% |
27,231
+509
| +2% | +$22.1K |
|
837
Loews
L
$19.8B
| $1.17M | ﹤0.01% |
23,214
-2,568
| -10% | -$130K |
|
838
Acadia Pharmaceuticals
ACAD
$4.08B
| $1.16M | ﹤0.01% |
72,700
| – | – |
|
839
Entegris
ENTG
$11.9B
| $1.16M | ﹤0.01% |
13,332
+750
| +6% | +$65.1K |
|
840
Allison Transmission
ALSN
$7.41B
| $1.16M | ﹤0.01% |
34,082
+1,232
| +4% | +$41.8K |
|
841
Energy Transfer Partners
ET
$59.6B
| $1.14M | ﹤0.01% |
102,980
| – | – |
|
842
Unum
UNM
$12.4B
| $1.14M | ﹤0.01% |
+29,400
| New | +$1.14M |
|
843
Genpact
G
$7.46B
| $1.14M | ﹤0.01% |
25,770
+25,208
| +4,485% | +$1.11M |
|
844
Old Republic International
ORI
$9.82B
| $1.13M | ﹤0.01% |
+53,117
| New | +$1.13M |
|
845
Lumentum
LITE
$11.6B
| $1.13M | ﹤0.01% |
16,405
-10,675
| -39% | -$732K |
|
846
HF Sinclair
DINO
$9.47B
| $1.12M | ﹤0.01% |
+21,100
| New | +$1.12M |
|
847
United Bankshares
UBSI
$5.35B
| $1.12M | ﹤0.01% |
+31,400
| New | +$1.12M |
|
848
POSCO
PKX
$15.5B
| $1.12M | ﹤0.01% |
29,517
| – | – |
|
849
Maravai LifeSciences
MRVI
$375M
| $1.11M | ﹤0.01% |
44,689
| – | – |
|
850
Arcus Biosciences
RCUS
$1.21B
| $1.11M | ﹤0.01% |
43,000
| – | – |
|